Compounds That Target MAP3K2

mitogen-activated protein kinase kinase kinase 2 · 31 compounds in BiohacksAI corpus

MAP3K2 (mitogen-activated protein kinase kinase kinase 2) is a biological target with 31 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MAP3K2 modulation for therapeutic and biohacking applications.

View MAP3K2 target page →UniProt: Q9Y2U5 ↗

Most Studied Compounds for MAP3K2

Crizotinib

298+

studies

All 31 Compounds — Ranked by Evidence

Gefitinib

5.67

confidence

Erlotinib

5.55

confidence

Alvocidib

4.52

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Ruxolitinib

4.23

confidence

Bosutinib

4.08

confidence

Midostaurin

3.85

confidence

Pazopanib

3.69

confidence

Neratinib

3.66

confidence

Nintedanib

3.61

confidence

Canertinib

3.53

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Gilteritinib

3.40

confidence

Dovitinib

3.09

confidence

At 9283

3.09

confidence

Lestaurtinib

3.04

confidence

Ruboxistaurin

2.94

confidence

R 406

2.83

confidence

K 252a

2.83

confidence

Pha 665752

2.71

confidence

Kw 2449

2.64

confidence

Gsk 690693

2.64

confidence

Ast 487

2.56

confidence

Motesanib

2.48

confidence

Su 014813

2.20

confidence

Decernotinib

2.20

confidence

Amg 900

2.08

confidence

Pf 03814735

1.79

confidence

Crizotinib

298+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MAP3K2 (mitogen-activated protein kinase kinase kinase 2). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MAP3K2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.